首页 | 本学科首页   官方微博 | 高级检索  
检索        

内皮源性硫化氢在雌激素抗动脉粥样硬化中的作用及机制
引用本文:吴强,林静,彭俊,李杰,付晓东,曹铭辉.内皮源性硫化氢在雌激素抗动脉粥样硬化中的作用及机制[J].中国病理生理杂志,2013,29(8):1375-1379.
作者姓名:吴强  林静  彭俊  李杰  付晓东  曹铭辉
作者单位:中山大学孙逸仙纪念医院 1麻醉科, 2手术室,广东 广州 510120; 3中山大学中山医学院生理学教研室,广东 广州 510080
基金项目:广东省医学科学技术研究基金资助项目,广东省科技计划
摘    要: 目的:探讨内皮源性硫化氢(H2S)在雌激素诱导的抗动脉粥样硬化过程中的作用及其机制。方法:在体外培养的人脐静脉内皮细胞(HUVECs)上观察17β-雌二醇(E2)促进H2S快速释放的效应,并进一步观察雌激素受体在此过程中的作用。在去势雌性ApoE–/–C57BL/6小鼠中建立动脉粥样硬化模型,实验分为去势组(OVX)、去势+E2治疗组(OVX+E2)、去势+E2+内源性H2S生成酶抑制剂DL-炔丙基甘氨酸(PPG)治疗组(OVX+E2+PPG),观察各组大鼠血液中H2S的浓度和动脉粥样斑块大小。结果:E2可以促进HUVECs快速释放H2S,且具有时间效应和浓度效应。雌激素受体α亚型激动剂丙基吡唑三醇(而不是β亚型激动剂二芳丙腈)可以模拟E2促H2S释放效应,雌激素受体拮抗剂ICI 182780可以阻断E2促H2S释放效应。在动物模型上,与OVX相比,OVX+E2组动脉粥样硬化明显改善,血液中H2S浓度升高;而OVX+E2+PPG组动脉粥样硬化无明显改善,H2S浓度无明显差异。结论: 雌激素通过细胞膜上的ERα促进内皮源性H2S的快速释放,H2S在雌激素抗动脉粥样硬化的过程中起着重要作用。

关 键 词:硫化氢  雌激素  动脉粥样硬化  受体  雌激素  
收稿时间:2013-04-12

Role and mechanism of endothelial hydrogen sulfide in anti-atherosclerosis effect of estrogen
WU Qiang , LIN Jing , PENG Jun , LI Jie , FU Xiao-dong , CAO Ming-hui.Role and mechanism of endothelial hydrogen sulfide in anti-atherosclerosis effect of estrogen[J].Chinese Journal of Pathophysiology,2013,29(8):1375-1379.
Authors:WU Qiang  LIN Jing  PENG Jun  LI Jie  FU Xiao-dong  CAO Ming-hui
Institution:1Department of Anesthesiology, 2Department of Operating Room, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China; 3Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.
Abstract:AIM:To investigate possible role and mechanism of endothelial hydrogen sulfide (H2S) in the anti-atherosclerosis effect of estrogen. METHODS:For in vitro experiment, cultured human umbilical vein endothelial cells (HUVECs) were treated with 17β-estradiol (E2), estrogen receptor α (ERα) agonist propylpyrazole triol (PPT), estrogen receptor β (ERβ) agonist diarylpropionitrile (DPN) and estrogen receptor antagonist ICI 182780 (ICI) for 5 min, and then the concentration of H2S in cell culture supernatants was detected by sensitive sulphur electrode assay. For in vivo experiment, high-fat diet-fed and ovariectomized (OVX) female ApoE–/– C57BL/6 mice were randomly divided into 3 groups and treated with placebo (OVX group), E2 (OVX+E2 group) and E2 plus cystathionine γ-lyase (CSE) inhibitor DL-propargylglycine (PPG) (OVX+E2+PPG group), respectively, and the blood concentration of H2S and the atherosclerotic plaque size were detected 8 weeks later. RESULTS:E2 significantly enhanced the release of H2S from HUVECs in a concentration-and time-dependant manner which could be blocked by the administration of ICI. Meanwhile, ERα  agonist  PPT, not ERβ agonist DPN, demonstrated similar effects to E2. Compared with OVX group, the atherosclerosis in mice was attenuated and the blood concentration of H2S was elevated in OVX+E2 group, while no significant changes were detected in OVX+E2+PPG group. CONCLUSION: Endothelial H2S can be rapidly released when membrane ERα is activated by estrogen, which plays a very important role in the anti-atherosclerosis effect of estrogen.
Keywords:Hydrogen sulfide  Estrogen  Atherosclerosis  Receptors  estrogen
本文献已被 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号